We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RBSH market cap is 32.13. The company's latest EPS is USD -0.0317 and P/E is 0.00.
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -1.02M | -664k |
Net Income | 2.7M | -1.02M |
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 715k | 5k |
Total Liabilities | 5.74M | 5.24M |
Total Equity | -5.02M | -5.24M |
Year End 31 December 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -693k | -706k |
Investing | N/A | N/A |
Financing | 1M | N/A |
Market Cap | 32.13 |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 32.13M |
Average Volume (1 week) | 68.38k |
Average Volume (1 Month) | 28.54k |
52 Week Change | -99.98% |
52 Week High | 0.01 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | Rebus Holdings Inc (CE) |
Address |
2140 s dupont hwy camden, delaware 19934 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions